Medical Plastics Market to Depict a CAGR of 7.1% over 2026 to 2034; SABIC to Showcase Medical-Grade Thermoplastics at MD&M West 2026 for a Strong Industry Standing

The global medical plastics market size stood at USD 35.93 billion in 2025. The market value is slated to rise from USD 39.05 billion in 2026 to USD 67.45 billion by 2034 at a CAGR of 7.1% during 2026-2034. Fortune Business Insights™ presents this information in its report titled “Medical Plastics Market Size, Share & Industry Analysis, By Application (Medical Disposables, Medical Instruments, Prosthetics & Implants, Drugs Packaging, and Others), and Regional Forecast, 2026-2034”.

The escalating surgical volume with the increasing incidences of chronic conditions is bolstering the demand for advanced medical devices, putting a spotlight on the role of plastics in medical equipment manufacturing. Recording a high usability on account of chemical resistance, biocompatibility, and lightweight attributes, medical plastics are touted to showcase a rising demand in hospital settings across various regions. The mounting demand for reducing hospital-acquired infections is impelling the adoption of single-use disposable devices and the development of cost-efficient and sterilizable components. The industry is also recording a rise in innovation and an elevated demand for flexible and durable polymers given the integration of wearable equipment with smart medical devices.   

BASF Rolled Out Ultrason® P 3010 BMB with Intent for Portfolio Expansion

In March 2026, BASF introduced Ultrason® P 3010 BMB as part of a move to expand its certified biomass-balanced polyarylethersulfones portfolio. The new solution is a polyphenylsulfone (PPSU) with 20% attributed bio-circular feedstock and has been rolled out for boosting transition toward a circular economy. The product would also help enhance the use of renewable resources across water and sanitary, household and catering, hydrogen production, and medical technology industries.

Market Value to Ramp up with Surge in Chronic Disease Prevalence

The rising prevalence of chronic conditions such as cardiovascular disorders, diabetes, and orthopedic diseases is pushing the demand for advanced devices, bolstering medical plastics market growth. The advantages offered by these plastics comprise resistance to the process of sterilization, flexibility in design, and cost efficiency. The mounting demand for durable and safe solutions for drug packaging is also supporting product consumption.

Nonetheless, fluctuations in the prices of raw materials may create an impact on profit margins, hampering the growth potential.

Leading Product Producers to Develop Regulatory Compliant and Safe Products for a Strong Foothold

With the stringency of regulatory standards for the healthcare sector, major producers of medical-grade plastics are emphasizing the development of products complying with safety, sterilization, and biocompatibility standards. The industry is witnessing the development of polymers that are lightweight, antimicrobial, and deliver high performance. Companies are also forging collaborations with manufacturers of medical devices for enhancing their medical plastics market share and gaining an edge against competition.

Key Players Profiled in the Report

• SABIC (Saudi Arabia)
• Celanese Corporation (U.S.)
• BASF SE (Germany)
• Evonik Industries AG (Germany)
• Syensqo SA (Belgium)
• Covestro AG (Germany)
• Röchling SE & Co. KG (Germany)
• Eastman Chemical Company (U.S.)
• DuPont (U.S.)
• Victrex plc (U.K.)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/medical-plastics-market-102136

Key Industry Development

• February 2026: SABIC shared plans for exhibiting its medical-grade thermoplastics at MD&M West 2026. The products planned for the exhibit comprise new biocompatible SILTEM™ HU resins and a new family of UL746G-certified polycarbonate (PC) copolymers. These solutions have been introduced for helping address challenges associated with production, performance, and regulatory compliance.

Further Report Findings

• The presence of well-established health infrastructure and the high volume of surgical procedures are impelling the dominance of North America in the global market. In this region, the U.S. market hit a valuation of USD 11.81 billion in 2025 considering the adoption of advanced technologies in the medical sector.
• In the Asia Pacific region, the demand for drug packaging solutions and disposable syringes is on the rise propelled by the escalating prevalence of chronic disorders. The medical plastics sector is likely to fare well in this region owing to substantial investments by governments in China, India, South Korea, and Japan toward the construction of hospital establishments and pharmaceutical production units.
• The Europe market is expanding driven by a surge in elderly population and a resultant demand for implants, prosthetics, and disposable medical devices. The launch of programs aimed at vaccine distribution and pharmaceutical manufacturing are also propelling the demand for medical plastics in the region.  

Table of Segmentation